Measurement of Lp(a) concentration in all adults at least once, so that results can be included in assessment of atherosclerotic cardiovascular disease (ASCVD) risk, is a key recommendation (COR 1; LOE B-NR) in the new dyslipidaemia guidelines drawn up by the American College of Cardiology and the American Heart Association (ACC/AHA) – the first since 2018.1
